Molecular understanding of Alzheimer Disease

Uncovering the unusual way aggregates hijack proteins

Utrecht scientists uncover how aggregates alter the behaviour of Tau protein, known to play a role in Alzheimer Disease. On a molecular level the researchers reveal why certain proteins tend to bind to Tau proteins. Key is the unusual way these proteins bind to Tau. They publish their findings January 29 in Nature Communications

Tau fibril
Tau fibrils

The hallmark of Alzheimer Disease is the death of neurons caused by aggregation of the Tau protein in the brain. Key is the formation of fibrils: long needle-like Tau protein aggregates. It is unclear, however, why these protein aggregations kills neurons. “There is no cure, simply because the molecular basis of the disease is poorly understood”, says last author Stefan Rüdiger, of the section Cellular Protein Chemistry at Utrecht University.

The researchers produced aggregates of the Alzheimer protein Tau and exposed them to a mixture containing all proteins that reside in the brain. “Mass spectrometric analysis revealed, that proteins binding exclusively to Tau aggregates belong to specific classes, known to play a role in Alzheimer development. Analysis of their composition revealed that they bind via an unusual mechanism to the Tau fibrils, so-called pi-stacking”, Rüdiger explains.

Tau monomer and tau fibril

This pancake-like stacking of Tau fibrils drives binding of protein to the Tau fibrils. In the publication the researchers reveal on a molecular level the mechanism behind the protein aggregation and how this impacts on cellular processes. This is an essential first step for targeting the cause of the disease.

“All diseases caused by protein aggregation – Parkinson, Huntington, Alzheimer – lack fundamental understanding of the disease”, says Rüdiger. “It is essential to understand the disease if we want to be able to treat it.”

This publication was a cooperation of four groups of Utrecht University:

Publication

Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau. Nature Communications, 29 januari 2020. Luca Ferrari, Riccardo Stucchi, Katerina Konstantoulea, Gerarda van de Kamp, Renate Kos, Willie J.C. Geerts, Laura S. van Bezouwen, Friedrich G. Förster, Maarten Altelaar, Casper C. Hoogenraad & Stefan G.D. Rüdiger. DOI 10.1038/s41467-019-13745-7

*All authors affiliated with Utrecht University and members of Science for Life.